The rich also get sick and die, but…
Bequest to future patients
Galina Papernaya, "Moscow News", 26.04.2012
The publication of disappointing diagnoses from iconic figures for the world economy – the heads of multinational corporations and investment funds – can cause a global collapse in the markets and shake the world economy considerably. However, these terrible news can also carry positive connotations: the struggle to save the lives of billionaires is being conducted with the allocation of considerable allocations for the latest medical developments. And financiers and industrialists can get into the history of medicine already as patients who will open access to new drugs and treatment methods for their fellow diagnoses in the future.
The news that the legendary American billionaire Warren Buffett has prostate cancer caused the stock market to collapse, despite the fact that the disease was detected at the earliest stage. The shares of Berkshire Hathaway holding, which is owned by Buffett, immediately lost 1% of their value. A similar effect was observed in 2011, when it became known that another American billionaire, Steve Jobs, was inferior in the fight against a deadly disease – Apple shares fell by 6% in a day.
By that time, the great founder of the IT company had been suffering from cancer for more than eight years, and Warren Buffett, as stated in the official statement on this matter, the disease was detected at the earliest stage. Another important circumstance, which also allows us to hope that the 81-year-old owner of the financial empire will still work, is the fact that his personal fortune, according to Forbes magazine, is $ 44 billion.
A few years ago, modern medicine, and in particular oncology, entered an era when life and health in some cases can literally be bought. The fact that Steve Jobs, with all his most difficult diagnoses, lived and worked actively for almost a decade, of course, is a considerable merit of the modern targeted technologies used for his treatment. In particular, drugs that exclusively affect cancer cells and spare healthy tissues were used for Jobs' therapy. This made it possible to avoid severe side effects for the body of the Apple executive, who, as is known, was distinguished by a specific approach to food.
Steve Jobs, thanks to targeted therapy, kept working even after several years of fighting cancer // © AP
As modern science already knows, there are hundreds of varieties of cancer cells, and in order to destroy a tumor, it is necessary to destroy a significant part of cells of all types. Combinations of different cells in each tumor are unique, therefore, modern medicine is a "cocktail" of various drugs.
So far, the price of a cure is millions of dollars. But, as the creators of targeted drugs assured MN, in the near future biotechnological drugs of a new type will be much cheaper, which will make them available not only for wealthy patients, but also for all people with oncological and autoimmune diseases.
Portal "Eternal youth" http://vechnayamolodost.ru28.04.2012